A rodent model of rapid-onset diabetes induced by glucocorticoids and high-fat feeding

DMM Disease Models and Mechanisms

Volumn 5, Issue 5, 2012, Pages 671-680

  Shpilberg, Yaniv ^a   Beaudry, Jacqueline L ^a   D'Souza, Anna ^a   Campbell, Jonathan E ^a   Peckett, Ashley ^a   Riddell, Michael C ^a  

^a YORK UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; CORTICOSTERONE; FATTY ACID; GLUCOCORTICOID RECEPTOR; INSULIN; LEPTIN; TRIACYLGLYCEROL; WAX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CIRCADIAN RHYTHM; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DISEASE MODEL; FATTY LIVER; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERPHAGIA; INSULIN RESISTANCE; LIPID DIET; LIPID STORAGE; MALE; METABOLIC SYNDROME X; MUSCLE ATROPHY; MUSCLE MASS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAPID ONSET DIABETES; RAT;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOSE TISSUE; ADIPOSITY; ANIMALS; BODY COMPOSITION; CIRCADIAN RHYTHM; CORTICOSTERONE; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ENERGY INTAKE; FASTING; FEEDING BEHAVIOR; GLUCOCORTICOIDS; HYPERGLYCEMIA; HYPERINSULINISM; HYPERPHAGIA; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; MUSCULAR ATROPHY; RATS; RECEPTORS, GLUCOCORTICOID; TRIGLYCERIDES; WEIGHT GAIN;

ANIMALIA; RATTUS; RODENTIA;

EID: 84865493185     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.008912     Document Type: Article

References (58)

1. Aleixandre de Artinano, A. and Miguel Castro, M. (2009). Experimental rat models to study the metabolic syndrome. Br. J. Nutr. 102, 1246-1253.
2. Anagnostis, P., Athyros, V. G., Tziomalos, K., Karagiannis, A. and Mikhailidis, D. P. (2009). Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J. Clin. Endocrinol. Metab. 94, 2692-2701.
3. Andersen, H., Gjerstad, M. D. and Jakobsen, J. (2004). Atrophy of foot muscles: a measure of diabetic neuropathy. Diabetes Care 27, 2382-2385. (Pubitemid 39281389)
4. Bays, H. E., Gonzalez-Campoy, J. M., Bray, G. A., Kitabchi, A. E., Bergman, D. A., Schorr, A. B., Rodbard, H. W. and Henry, R. R. (2008). Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev. Cardiovasc. Ther. 6, 343-368.
5. Bray, G. A., Jablonski, K. A., Fujimoto, W. Y., Barrett-Connor, E., Haffner, S., Hanson, R. L., Hill, J. O., Hubbard, V., Kriska, A. and Stamm, E. (2008). Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am. J. Clin. Nutr. 87, 1212-1228.
6. Bujalska, I. J., Draper, N., Michailidou, Z., Tomlinson, J. W., White, P. C., Chapman, K. E., Walker, E. A. and Stewart, P. M. (2005). Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1. J. Mol. Endocrinol. 34, 675-684. (Pubitemid 40903593)
7. Campbell, J. E., Király, M. A., Atkinson, D. J., D'souza, A. M., Vranic, M. and Riddell, M. C. (2010). Regular exercise prevents the development of hyperglucocorticoidemia via adaptations in the brain and adrenal glands in male Zucker diabetic fatty rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299, R168-R176.
8. Ceddia, R. B. (2005). Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis. Int. J. Obes. (Lond.) 29, 1175-1183.
9. Chan, O., Inouye, K., Riddell, M. C., Vranic, M. and Matthews, S. G. (2003). Diabetes and the hypothalamo-pituitary-adrenal (HPA) axis. Minerva Endocrinol. 28, 87-102.
10. Clark, J. B., Palmer, C. J. and Shaw, W. N. (1983). The diabetic Zucker fatty rat. Proc. Soc. Exp. Biol. Med. 173, 68-75. (Pubitemid 13088195)
11. Coleman, D. L. (1978). Obese and diabetes: two mutant genes causing diabetesobesity syndromes in mice. Diabetologia 14, 141-148.
12. Coleman, D. L. and Hummel, K. P. (1973). The influence of genetic background on the expression of the obese (Ob) gene in the mouse. Diabetologia 9, 287-293.
13. Dallman, M. F. (2003). Fast glucocorticoid feedback favors 'the munchies'. Trends Endocrinol. Metab. 14, 394-396.
14. Dallman, M. F. (2010). Stress-induced obesity and the emotional nervous system. Trends Endocrinol. Metab. 21, 159-165.
15. Dong, H., Lin, H., Jiao, H. C., Song, Z. G., Zhao, J. P. and Jiang, K. J. (2007). Altered development and protein metabolism in skeletal muscles of broiler chickens (Gallus gallus domesticus) by corticosterone. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 147, 189-195. (Pubitemid 46467458)
16. Eckel, R. H., Kahn, S. E., Ferrannini, E., Goldfine, A. B., Nathan, D. M., Schwartz, M. W., Smith, R. J. and Smith, S. R. (2011). Obesity and type 2 diabetes: what can be unified and what needs to be individualized? J. Clin. Endocrinol. Metab. 96, 1654-1663.
17. Falduto, M. T., Czerwinski, S. M. and Hickson, R. C. (1990). Glucocorticoid-induced muscle atrophy prevention by exercise in fast-twitch fibers. J. Appl. Physiol. 69, 1058-1062. (Pubitemid 20338710)
18. Finegood, D. T., McArthur, M. D., Kojwang, D., Thomas, M. J., Topp, B. G., Leonard, T. and Buckingham, R. E. (2001). Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes 50, 1021-1029. (Pubitemid 32374532)
19. Gathercole, L. L. and Stewart, P. M. (2010). Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes. J. Steroid Biochem. Mol. Biol. 122, 21-27.
20. Giacca, A., Xiao, C., Oprescu, A. I., Carpentier, A. C. and Lewis, G. F. (2011). Lipidinduced pancreatic beta-cell dysfunction: focus on in vivo studies. Am. J. Physiol. Endocrinol. Metab. 300, E255-E262.
21. Gounarides, J. S., Korach-Andre, M., Killary, K., Argentieri, G., Turner, O. and Laurent, D. (2008). Effect of dexamethasone on glucose tolerance and fat metabolism in a diet-induced obesity mouse model. Endocrinology 149, 758-766. (Pubitemid 351159344)
22. Gurwitz, J. H., Bohn, R. L., Glynn, R. J., Monane, M., Mogun, H. and Avorn, J. (1994). Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch. Intern. Med. 154, 97-101. (Pubitemid 24018107)
23. Gustavsson, C., Soga, T., Wahlstrom, E., Vesterlund, M., Azimi, A., Norstedt, G. and Tollet-Egnell, P. (2011). Sex-dependent hepatic transcripts and metabolites in the development of glucose intolerance and insulin resistance in Zucker diabetic fatty rats. J. Mol. Endocrinol. 47, 129-143.
24. Hans, P., Vanthuyne, A., Dewandre, P. Y., Brichant, J. F. and Bonhomme, V. (2006). Blood glucose concentration profile after 10 mg dexamethasone in non-diabetic and type 2 diabetic patients undergoing abdominal surgery. Br. J. Anaesth. 97, 164-170. (Pubitemid 44295700)
25. Herder, C., Karakas, M. and Koenig, W. (2011). Biomarkers for the prediction of type 2 diabetes and cardiovascular disease. Clin. Pharmacol. Ther. 90, 52-66.
26. Huang, B. K., Monu, J. U. and Doumanian, J. (2010). Diabetic myopathy: MRI patterns and current trends. Am. J. Roentgenol. 195, 198-204.
27. Islam, M. S. and Loots, D. T. (2009). Experimental rodent models of type 2 diabetes: a review. Methods Find. Exp. Clin. Pharmacol. 31, 249-261.
28. Karatsoreos, I. N., Bhagat, S. M., Bowles, N. P., Weil, Z. M., Pfaff, D. W. and McEwen, B. S. (2010). Endocrine and physiological changes in response to chronic corticosterone: a potential model of the metabolic syndrome in mouse. Endocrinology 151, 2117-2227.
29. Kawano, K., Hirashima, T., Mori, S., Saitoh, Y., Kurosumi, M. and Natori, T. (1992). Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41, 1422-1428.
30. Kennedy, A. J., Ellacott, K. L., King, V. L. and Hasty, A. H. (2010). Mouse models of the metabolic syndrome. Dis. Model. Mech. 3, 156-166.
31. Koopman, R., Schaart, G. and Hesselink, M. K. (2001). Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochem. Cell Biol. 116, 63-68. (Pubitemid 32695819)
32. Kumar, V., Madhu, S. V., Singh, G. and Gambhir, J. K. (2010). Post-prandial hypertriglyceridemia in patients with type 2 diabetes mellitus with and without macrovascular disease. J. Assoc. Physicians India 58, 603-607.
33. Lansang, M. C. and Hustak, L. K. (2011). Glucocorticoid-induced diabetes and adrenal suppression: How to detect and manage them. Cleve. Clin. J. Med. 78, 748-756.
34. Lara-Castro, C. and Garvey, W. T. (2008). Intracellular lipid accumulation in liver and muscle and the insulin resistance syndrome. Endocrinol. Metab. Clin. North Am. 37, 841-856.
35. LeBrasseur, N. K., Walsh, K. and Arany, Z. (2011). Metabolic benefits of resistance training and fast glycolytic skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 300, E3-E10.
36. Luijf, Y. M., Hermanides, J., Serlie, M. J., Hoekstra, J. B. and Soeters, M. R. (2011). The added value of oral glucose tolerance testing in pre-diabetes. Curr. Diabetes Rev. 7, 56-60.
37. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. C. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419. (Pubitemid 15018832)
38. Matthews, L. C. and Hanley, N. A. (2011). The stress of starvation: glucocorticoid restraint of beta cell development. Diabetologia 54, 223-226.
39. Meyer, J. S., Micco, D. J., Stephenson, B. S., Krey, L. C. and McEwen, B. S. (1979). Subcutaneous implantation method for chronic glucocorticoid replacement therapy. Physiol. Behav. 22, 867-870. (Pubitemid 9214715)
40. Panthakalam, S., Bhatnagar, D. and Klimiuk, P. (2004). The prevalence and management of hyperglycaemia in patients with rheumatoid arthritis on corticosteroid therapy. Scott. Med. J. 49, 139-141. (Pubitemid 40074419)
41. Pasternak, J. J., McGregor, D. G. and Lanier, W. L. (2004). Effect of single-dose dexamethasone on blood glucose concentration in patients undergoing craniotomy. J. Neurosurg. Anesthesiol. 16, 122-125. (Pubitemid 39090032)
42. Peckett, A. J., Wright, D. C. and Riddell, M. C. (2011). The effects of glucocorticoids on adipose tissue lipid metabolism. Metabolism 60, 1500-1510
43. Poitout, V., Amyot, J., Semache, M., Zarrouki, B., Hagman, D. and Fontes, G. (2010). Glucolipotoxicity of the pancreatic beta cell. Biochim. Biophys. Acta 1801, 289-298.
44. Pour, O. R. and Dagogo-Jack, S. (2011). Prediabetes as a therapeutic target. Clin. Chem. 57, 215-220.
45. Reed, M. J., Meszaros, K., Entes, L. J., Claypool, M. D., Pinkett, J. G., Gadbois, T. M. and Reaven, G. M. (2000). A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism 49, 1390-1394.
46. Reynolds, R. M. (2010). Corticosteroid-mediated programming and the pathogenesis of obesity and diabetes. J. Steroid Biochem. Mol. Biol. 122, 3-9.
47. Rolland, V., Clement, K., Dugail, I., Guy-Grand, B., Basdevant, A., Froguel, P. and Lavau, M. (1998). Leptin receptor gene in a large cohort of massively obese subjects: no indication of the fa/fa rat mutation. Detection of an intronic variant with no association with obesity. Obes. Res. 6, 122-127. (Pubitemid 128679652)
48. Rose, A. J., Vegiopoulos, A. and Herzig, S. (2010). Role of glucocorticoids and the glucocorticoid receptor in metabolism: insights from genetic manipulations. J. Steroid Biochem. Mol. Biol. 122, 10-20.
49. Rosmond, R. (2005). Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology 30, 1-10.
50. Roy, M., Collier, B. and Roy, A. (1990). Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients. Psychiatry Res. 31, 31-37. (Pubitemid 20049542)
51. Samuel, V. T., Petersen, K. F. and Shulman, G. I. (2010). Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375, 2267-2277.
52. Stewart, P. M. (1996). 11 beta-Hydroxysteroid dehydrogenase: implications for clinical medicine. Clin. Endocrinol. 44, 493-499.
53. Tomiyama, A. J., Dallman, M. F. and Epel, E. S. (2011). Comfort food is comforting to those most stressed: Evidence of the chronic stress response network in high stress women. Psychoneuroendocrinology 36, 1513-1519.
54. Unger, R. H. (2003). Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 144, 5159-5165.
55. Unger, R. H., Clark, G. O., Scherer, P. E. and Orci, L. (2010). Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim. Biophys. Acta 1801, 209-214.
56. van der Zijl, N. J., Goossens, G. H., Moors, C. C., van Raalte, D. H., Muskiet, M. H., Pouwels, P. J., Blaak, E. E. and Diamant, M. (2011). Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on beta-cell function in individuals with impaired glucose metabolism. J. Clin. Endocrinol. Metab. 96, 459-467.
57. van Raalte, D. H., Ouwens, D. M. and Diamant, M. (2009). Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur. J. Clin. Invest. 39, 81-93.
58. Wang, Y., Nakagawa, Y., Liu, L., Wang, W., Ren, X., Anghel, A., Lutfy, K., Friedman, T. C. and Liu, Y. (2011). Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes. Diabetologia 54, 440-450.